BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11278268)

  • 1. Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40.
    Luftig MA; Cahir-McFarland E; Mosialos G; Kieff E
    J Biol Chem; 2001 May; 276(18):14602-6. PubMed ID: 11278268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation.
    Luftig M; Yasui T; Soni V; Kang MS; Jacobson N; Cahir-McFarland E; Seed B; Kieff E
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):141-6. PubMed ID: 14691250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor I.
    Matsushima A; Kaisho T; Rennert PD; Nakano H; Kurosawa K; Uchida D; Takeda K; Akira S; Matsumoto M
    J Exp Med; 2001 Mar; 193(5):631-6. PubMed ID: 11238593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-kappaB activation.
    Song YJ; Kang MS
    Virus Genes; 2010 Oct; 41(2):174-80. PubMed ID: 20585848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.
    Sylla BS; Hung SC; Davidson DM; Hatzivassiliou E; Malinin NL; Wallach D; Gilmore TD; Kieff E; Mosialos G
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10106-11. PubMed ID: 9707608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase.
    Shinkura R; Kitada K; Matsuda F; Tashiro K; Ikuta K; Suzuki M; Kogishi K; Serikawa T; Honjo T
    Nat Genet; 1999 May; 22(1):74-7. PubMed ID: 10319865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts.
    Smith C; Andreakos E; Crawley JB; Brennan FM; Feldmann M; Foxwell BM
    J Immunol; 2001 Nov; 167(10):5895-903. PubMed ID: 11698466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
    Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
    Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536.
    Jiang X; Takahashi N; Matsui N; Tetsuka T; Okamoto T
    J Biol Chem; 2003 Jan; 278(2):919-26. PubMed ID: 12419817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation.
    Song YJ; Jen KY; Soni V; Kieff E; Cahir-McFarland E
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2689-94. PubMed ID: 16477006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression.
    Miller WE; Cheshire JL; Raab-Traub N
    Mol Cell Biol; 1998 May; 18(5):2835-44. PubMed ID: 9566902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.
    Shkoda A; Town JA; Griese J; Romio M; Sarioglu H; Knöfel T; Giehler F; Kieser A
    PLoS Biol; 2012; 10(8):e1001376. PubMed ID: 22904686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIK-IKK complex interaction controls NF-κB-dependent inflammatory activation of endothelium in response to LTβR ligation.
    Kucharzewska P; Maracle CX; Jeucken KCM; van Hamburg JP; Israelsson E; Furber M; Tas SW; Olsson HK
    J Cell Sci; 2019 Apr; 132(7):. PubMed ID: 30837284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
    Miller WE; Mosialos G; Kieff E; Raab-Traub N
    J Virol; 1997 Jan; 71(1):586-94. PubMed ID: 8985387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression.
    Devergne O; Cahir McFarland ED; Mosialos G; Izumi KM; Ware CF; Kieff E
    J Virol; 1998 Oct; 72(10):7900-8. PubMed ID: 9733827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways.
    Müller JR; Siebenlist U
    J Biol Chem; 2003 Apr; 278(14):12006-12. PubMed ID: 12556537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.
    Kung CP; Raab-Traub N
    J Virol; 2010 Jul; 84(13):6605-14. PubMed ID: 20410275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.
    Luftig M; Prinarakis E; Yasui T; Tsichritzis T; Cahir-McFarland E; Inoue J; Nakano H; Mak TW; Yeh WC; Li X; Akira S; Suzuki N; Suzuki S; Mosialos G; Kieff E
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15595-600. PubMed ID: 14673102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1.
    Wu L; Nakano H; Wu Z
    J Biol Chem; 2006 Jan; 281(4):2162-9. PubMed ID: 16280329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.